Mention of positive LOI with pCPA
Is it permissible to include a callout in a branded APS that simply mentions a positive LOI with pCPA for a particular indication, once that agreement has been publicized? Appropriate balance information would be included.
Jennifer Carroll last edited by
Please see the response to Q&A Email update on CADTH recommendations. The letter of intent (LOI) is viewed similarly to the CADTH recommendation. It is not acceptable to position the pan-Canadian Pharmaceutical Alliance (pCPA) coverage negotiations as a positive feature of the product or suggest endorsement. Formulary messages should be restricted to clear, complete coverage criteria and not suggest the endorsement of a product.